-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on US Physical Therapy, Lowers Price Target to $110

Benzinga·03/19/2025 14:19:47
Listen to the news
JP Morgan analyst Calvin Sternick maintains US Physical Therapy (NYSE:USPH) with a Overweight and lowers the price target from $120 to $110.